Results 91 to 100 of about 4,771 (191)

Supplementary Figure 1 from A Phase I/II Trial of Belinostat in Combination with Cisplatin, Doxorubicin, and Cyclophosphamide in Thymic Epithelial Tumors: A Clinical and Translational Study

open access: yes, 2014
Mean plasma concentration vs. time curve at belinostat 250 mg/m2.
Ariel Lopez-Chavez (14984835)   +17 more
core   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Belinostat effects on expression Of RBM5 tumor suppressor gene and inhibits prostate cancer cell line (PC3) proliferation

open access: yes, 2018
Prostate cancer as the second most prevalent cancer and the sixth most common cause of cancer death among men appears with increasing mortality incidence rate amongst Asian population.
Nikbakht-Dastjerdi, Mehdi   +3 more
core   +1 more source

Pharmacokinetic and pharmacodynamic properties of an oral formulation of the histone deacetylase inhibitor Belinostat (PXD101)

open access: yes, 2010
The primary objective of this sub-study, undertaken as an extension to the previously reported phase-I study, was to explore the feasibility, tolerability and pharmacokinetics (PK) of belinostat when administered by the oral route.
de Bono, J. S.   +19 more
core   +1 more source

LINFOMA DE LENNERT: RELATO DE CASO

open access: yesHematology, Transfusion and Cell Therapy
Introdução: O linfoma de Lennert ou linfoma linfoepitelióide é um subtipo raro de linfoma T. Os linfomas T periféricos são um grupo de doenças heterogêneas, com uma sobrevida global menor do que 32% em 5 anos. Relato de caso: Paciente masculino, 27 anos,
AP Gouvea   +9 more
doaj   +1 more source

IHC staining of transgenic mice bladders for , the cell proliferation marker Ki67 and , P21 in L-Arginine treated (left panel) and belinostat-treated bladder cancer mice (right panel)

open access: yes, 2011
Copyright information:Taken from "The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo"http://www.translational-medicine.com/content/5/1/49Journal of Translational Medicine 2007;5():49-49 ...
Joanne Yoon (37162)   +10 more
core   +1 more source

Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors

open access: yes, 2011
Purpose Thymic epithelial tumors are rare malignancies, and there is no standard treatment for patients with advanced disease in whom chemotherapy has failed. Antitumor activity of histone deacetylase (HDAC) inhibitors in this disease has been documented,
Arun Rajan   +11 more
core   +1 more source

CREB binding protein (CREBBP): Structure-based perspectives for the development of clinical inhibitors

open access: yesTranslational Oncology
Acetylation is an essential process in biological processes. In tissues, protein acetylation occurs mainly at lysine (K) residues. The balance between acetylation and deacetylation is under the control of two enzyme families, histone acetyltransferase ...
Rongxing Liu   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy